Page 1960 - Week 05 - Thursday, 16 May 2019
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video
(4) The report “Implementing Trauma Informed Practice in the ACT Specialist Homelessness Services Project: Final Report to the Specialist Homelessness Sector” will be made publicly available to the ACT Specialist Homelessness Sector through the Sector’s ‘Joint Pathways’ forum.
(5) Government will not be providing a formal response to the findings and recommendations of the Report. The purpose of commissioning this research was to form an initial evidence base to develop a longer term strategy to contribute to developing a trauma informed ACT Specialist Homelessness Sector.
(6) Government is currently undertaking procurement activities to use the remainder of the $350,000 (excl. GST) to engage a trainer(s) to deliver online introductory trauma training; advanced trauma training and train-the-trainer trauma training program for practice champions.
(7) The remainder of the $350,000 (excl. GST) will be committed to purchase the services outlined at Question 6, by 30 June 2019.
(8) ACT Government recognises that people accessing ACT Specialist Homelessness Services often have a lived experience of trauma. We are therefore committed to ensuring ACT homelessness service delivery is trauma informed. The need for additional funding will be evaluated following implementation of the first stage of activities from the Report.
ACT Health—medicinal cannabis scheme
(Question No 2381)
Ms Le Couteur asked the Minister for Health and Wellbeing, upon notice, on 22 March 2019:
(1) How many prescriptions for medicinal cannabis have been filled in the ACT since the ACT Medicinal Cannabis Scheme started in 2016.
(2) To how many prescribers has the ACT Chief Health Officer provided approval to allow the prescription of medicinal cannabis as a controlled medicine.
(3) What is the average time taken for ACT Health to provide a response to an application for a Medicinal Cannabis Prescriber Approval.
(4) What approval processes do pharmacists in the ACT have to undergo through ACT Health in order to obtain medicinal cannabis products for patients in addition to the approvals required through the TGA and the Office of Drug Control.
(5) How is ACT Health’s approval process for prescribing medicinal cannabis different to the approval process for prescribing other controlled medicines and why do these products have different approval processes.
(6) When was the last meeting of the Medicinal Cannabis Medical Advisory Panel and can the Minister provide a copy of the minutes of the last meeting.
(7) Has the Medicinal Cannabis Medical Advisory Panel given approval for the prescription of medicinal cannabis for any other condition other than those listed
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video